Changing trends in antimicrobial resistance of major bacterial pathogens, 1985-2005: A study from a medical center in northern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 2, 2011, Pages 131-138

  Lo, Wen Tsung ^a   Lin, Wei Jen ^a   Chiueh, Tzong Shi ^a   Lee, Shi Yi ^b   Wang, Chih Chien ^a   Lu, Jang Jih ^a,c,d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

21 years; Antimicrobial resistance; Gram negative bacteria; Gram positive bacteria; Taiwan

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; IMIPENEM; METICILLIN; OXACILLIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; INCIDENCE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RETROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; TAIWAN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 79952899092     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmii.2010.02.004     Document Type: Article

References (36)

1. Archibald L., Philips L., Monnet D., McGowan J.L., Tenover F., Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997, 24:211-215.
2. Flamm R.K., Weaver M.K., Thornsberry C., Johns M.E., Karlowsky J.A., Sahm D.F. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004, 48:2431-2436.
3. Rhomberg P.R., Jones R.N., Sader H.S. Results from the Meropenem Yearly Susceptibility Test Information Collection (MYS-TIC) Programme: report of the 2001 data from 15 United States medical centres. Int J Antimicrob Agents 2004, 23:52-59. MYSTIC Programme (US) Study Group.
4. Sader H.S., Biedenbach D.J., Jones R.N. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). Diagn Microbiol Infect Dis 2003, 47:361-364.
5. Hsueh P.R., Liu C.Y., Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 2002, 8:132-137.
6. McDonald L.C., Lauderdale T.L., Shiau Y.R., Chen P.C., Lai J.F., Wang H.Y., et al. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents 2004, 23:362-370.
7. Hsueh P.R., Chen W.H., Teng L.J., Luh K.T. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 2005, 26:43-49.
8. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004, 48:2101-2107.
9. Hsueh P.R., Luh K.T. Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerg Infect Dis 2002, 8:1487-1491.
10. Hsueh P.R., Liu Y.C., Yang D., Yan J.J., Wu T.L., Huang W.K., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 2001, 7:373-382.
11. Hsueh P.R., Chen M.L., Sun C.C., Chen W.H., Pan H.J., Yang L.S., et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis 2002, 8:63-68.
12. Lauderdale T.L., Clifford McDonald L., Shiau Y.R., Chen P.C., Wang H.Y., Lai J.F., et al. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn Microbiol Infect Dis 2004, 48:211-219.
13. Sheng W.H., Chen Y.C., Wang J.T., Chang S.C., Luh K.T., Hsieh W.C. Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan. Diagn Microbiol Infect Dis 2002, 43:141-147.
14. Hsueh P.R., Chen W.H., Luh K.T. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J of Antimicrob Agents 2005, 26:463-472.
15. Chang S.C., Hsieh W.C., Liu C.Y. High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan. The Antibiotic Resistance Study Group of the Infectious Disease Society of the Republic of China. Diagn Microbiol Infect Dis 2000, 36:107-112.
16. Hsueh P.R., Shyr J.M., Wu J.J. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 2005, 40:903-905.
17. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disc susceptibility test-eighth edition: approved standard M2-A8 2003, NCCLS, Wayne, PA.
18. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing; 15th informational supplement M100-S15 2005, NCCLS, Wayne, PA.
19. Chang S.C., Hsu L.Y., Luh K.T., Hsieh W.C. Methicillin-resistant Staphylococcus aureus infections. J Formos Med Assoc 1988, 87:157-163.
20. Chen M.L., Chang S.C., Pan H.J., Hsueh P.R., Yang L.S., Ho S.W., et al. Longitudinal analysis of methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Formos Med Assoc 1999, 98:426-432.
21. Wu K.C., Chiu H.H., Wang J.H., Lee N.S., Lin H.C., Hsieh C.C., et al. Characteristics of community-acquired methicillin-resistant Staphylococcus aureus in infants and children without known risk factors. J Microbiol Immunol Infect 2002, 35:53-56.
22. Wang C.C., Lo W.T., Chu M.L., Siu L.K. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004, 39:481-487.
23. Chen C.J., Huang Y.C., Chiu C.H., Su L.H., Lin T.Y. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J 2005, 24:40-45.
24. T or SCC mec type IV. J Clin Microbiol 2005, 43:4719-4730.
25. Lo W.T., Lin W.J., Tseng M.H., Wang S.R., Chu M.L., Wang C.C. Community-acquired methicillin-resistant Staphylococcus aureus in children. Taiwan Emerg Infect Dis 2006, 12:1267-1270.
26. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001, 32:S114-S132.
27. Lu J.J., Lee S.Y., Hwa S.Y., Yang A.H. Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2005, 43:4156-4158.
28. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999, 27:520-532.
29. McDonald L.C. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006, 42:S65-S71.
30. McDonald L.C., Yu H.T., Yin H.C., Hsiung C.A., Hung C.C., Ho M., et al. Correlates of antibiotic use in Taiwan hospitals. Infect Control Hosp Epidemiol 2001, 22:565-571.
31. Hsueh P.R. Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan. Clin Microbiol Infect 2005, 11:925-927.
32. Jean S.S., Teng L.J., Hsueh P.R., Ho S.W., Luh K.T. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese university hospital. J Antimicrob Chemother 2002, 49:69-76.
33. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., et al. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005, 52:323-329.
34. Liao C.H., Sheng W.H., Wang J.T., Sun H.Y., Wang H.K., Hsueh P.R., et al. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan. J Microbiol Immunol Infect 2006, 39:59-66.
35. Ramphal R., Ambrose P.G. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 2006, 42:S164-S172.
36. Warren D.K., Frasser V.J. Infection control measures to limit antimicrobial resistance. Crit Care Med 2001, 29:N128-N134.